Garcia Vanessa Athaíde, Souza de Freitas Betânia, Busato Stefano Boemler, D'avila Portal Bernardo Chaves, Piazza Francisco Correa, Schröder Nadja
Neurobiology and Developmental Biology Laboratory, Faculty of Biosciences, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil; National Institute for Translational Medicine (INCT-TM), 90035-003 Porto Alegre, RS, Brazil.
Neurobiology and Developmental Biology Laboratory, Faculty of Biosciences, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil.
Neuropharmacology. 2013 Dec;75:304-11. doi: 10.1016/j.neuropharm.2013.07.038. Epub 2013 Aug 16.
Modafinil is a wake-promoting drug and has been approved for the treatment of excessive daytime sleepiness in narcolepsy and obstructive sleep apnea. Modafinil was shown to improve learning and memory in rodents, and to reverse memory deficits induced by sleep deprivation or stress. However, depending on the memory paradigm used, modafinil might also impair memory. We aimed to investigate the effects of modafinil on memory consolidation and retrieval for object recognition and inhibitory avoidance in naïve adult rats. We also investigated whether acute or chronic administration of modafinil would reverse memory deficits induced by iron overload, a model of memory impairment related to neurodegenerative disorders. Adult naïve rats received modafinil (0.0, 0.75, 7.5 or 75 mg/kg) either immediately after training or 1 h prior to testing in object recognition or inhibitory avoidance. Iron-treated rats received modafinil immediately after training in object recognition. In order to investigate the effects of chronic modafinil, iron-treated rats received daily injections of modafinil for 17 days, and 24 h later they were trained in object recognition or inhibitory avoidance. Acute modafinil does not affect memory consolidation or retrieval in naive rats. A single injection of modafinil at the highest dose was able to recover recognition memory in iron-treated rats. Chronic modafinil completely recovered iron-induced recognition memory and emotional memory deficits. Additional preclinical and clinical studies are necessary in order to support the applicability of modafinil in recovering memory impairment associated with neurodegenerative disorders.
莫达非尼是一种促醒药物,已被批准用于治疗发作性睡病和阻塞性睡眠呼吸暂停中的日间过度嗜睡。研究表明,莫达非尼可改善啮齿动物的学习和记忆,并逆转由睡眠剥夺或应激引起的记忆缺陷。然而,根据所使用的记忆范式,莫达非尼也可能损害记忆。我们旨在研究莫达非尼对成年未处理大鼠物体识别和抑制性回避的记忆巩固和提取的影响。我们还研究了急性或慢性给予莫达非尼是否能逆转铁过载(一种与神经退行性疾病相关的记忆损伤模型)引起的记忆缺陷。成年未处理大鼠在物体识别或抑制性回避训练后立即或在测试前1小时接受莫达非尼(0.0、0.75、7.5或75mg/kg)。铁处理大鼠在物体识别训练后立即接受莫达非尼。为了研究慢性莫达非尼的作用,铁处理大鼠每天注射莫达非尼,持续17天,24小时后进行物体识别或抑制性回避训练。急性莫达非尼不影响未处理大鼠的记忆巩固或提取。单次注射最高剂量的莫达非尼能够恢复铁处理大鼠的识别记忆。慢性莫达非尼完全恢复了铁诱导的识别记忆和情绪记忆缺陷。为了支持莫达非尼在恢复与神经退行性疾病相关的记忆损伤中的适用性,还需要进行更多的临床前和临床研究。